Comeback Mobility

The People Building It

Comeback Mobility was founded in 2020 by Ilya Popov, whose personal experience with a prolonged forearm fracture recovery served as the catalyst for the venture [Comeback Mobility]. The company operates with a dual headquarters structure, maintaining its primary base in Dnipro, Ukraine, and a U.S. presence in Jackson, Wyoming [ZoomInfo, ~2023].

The Company in Brief

Key operational milestones have centered on product development and regulatory clearance. The company's core product, the Smart Crutch Tip, is described as a Class II medical device that is 510(k) exempt, indicating its FDA-cleared status for orthopedic rehabilitation monitoring [Comeback Mobility request page]. In a significant financial milestone, the company secured a $1 million seed round, led by the Ukrainian medtech fund Fison with participation from pharmaceutical firm Farmak and angel investor Peter Chernyshov [ZoomInfo, ~2023]. The team has grown to an estimated 21-50 employees, and has established a clinical research division focused on generating evidence for orthopedic trauma recovery [Comeback Mobility].

Data Accuracy: YELLOW -- Core facts (founding year, CEO, product description) are confirmed by the company and Crunchbase. Funding amount and investor list are reported by ZoomInfo but lack corroboration from major financial press. Employee count is an estimate from LinkedIn.

What They Have Built

The core product is a hardware-software system designed to bring quantitative measurement to a traditionally subjective process. Comeback Mobility's Smart Crutch Tips are physical sensors that attach to standard crutches or canes (17-30mm diameter) to monitor the weight a patient places on an injured lower limb in real time [Comeback Mobility]. The data is transmitted to a companion mobile application, providing biofeedback to the patient and creating a remote monitoring dashboard for their healthcare provider [Perplexity Sonar Pro]. This addresses a fundamental clinical challenge: ensuring patients adhere to prescribed weight-bearing limits, which is critical for healing but difficult to enforce outside a clinical setting.

The company's public positioning emphasizes a data-driven, personalized approach to rehabilitation protocols. A key differentiator cited is the integration of postoperative CT scan analysis with finite element analysis (FEA) to generate patient-specific weight-bearing prescriptions, moving beyond generic guidelines [Comeback Mobility]. The software layer appears to serve two primary functions: a patient-facing app for real-time feedback and a provider-facing platform for tracking compliance and outcomes. The company states the device is a Class II medical device and is 510(k) exempt [Comeback Mobility request page]; a separate source indicates it has received FDA clearance [Perplexity Sonar Pro].

Beyond the commercial product, the company is actively engaged in clinical research, which it frames as a core competency. Its website details a dedicated Clinical Recovery Organization (CRO) arm that partners with trauma surgeons to conduct specialized studies in orthopedic trauma [Comeback Mobility]. An announced clinical study aims to compare standard rehabilitation, guideline-based recommendations, and its personalized FEA-based protocols for hip and shin fractures [Comeback Mobility].

Data Accuracy: YELLOW -- Core product description is confirmed by company sources; FDA clearance status is cited by a single secondary source and not directly on the company's public-facing pages. Technical specifications for device compatibility are publicly listed.

Market Size and Demand

The market for orthopedic remote patient monitoring is defined by a persistent clinical problem, where patient non-compliance with weight-bearing restrictions after surgery leads to costly complications and extended recoveries. Comeback Mobility's cited research points to a substantial underlying patient population, but the more compelling driver is the economic pressure on healthcare systems to reduce readmissions and length of stay [Comeback Mobility].

According to a founder quote captured by Crunchbase, the company cites a global annual injury figure of 65.8 million people, with nearly 8.5 million lower extremity fractures and 2.1 million patients requiring rehabilitation lasting more than six weeks [Crunchbase].

Metric	Value
Global Annual Injuries	65.8 million people
Lower Extremity Fractures	8.5 million people
Rehab >6 Weeks	2.1 million people

Data Accuracy: YELLOW -- Market sizing figures are attributed to a founder quote via Crunchbase without independent third-party report corroboration.

Who Else Is Fighting for This

Comeback Mobility's competitive position is defined by its focus on a specific, hardware-enabled point solution for orthopedic weight-bearing monitoring, a niche that sits between traditional rehabilitation aids and broader digital health platforms.

Comeback Mobility's defensible edge today rests on its regulatory clearance and proprietary dataset. The company claims its device is FDA-cleared, a significant barrier for new entrants in the medical device space [Perplexity Sonar Pro]. Furthermore, its clinical approach is built on generating personalized weight-bearing prescriptions from post-operative CT scans using finite element analysis, creating a data asset tied to specific fracture types and healing outcomes [Comeback Mobility].

Data Accuracy: YELLOW -- Competitive analysis is inferred from company positioning and adjacent market players; no direct named competitors were identified in sources.

Opportunity

The potential prize for Comeback Mobility is the establishment of a new, data-driven standard of care in post-operative orthopedic rehabilitation, a market where even modest penetration could translate to a multi-hundred-million-dollar enterprise.

Scenario	What happens	Catalyst	Why it's plausible
Protocol Standardization	The company's clinical study validates superior outcomes, leading major orthopedic associations to recommend its protocol.	Publication of positive clinical trial results in a major journal.	The company is actively conducting "highly specialized clinical studies" with trauma surgeons to generate evidence [Comeback Mobility].
Health System Land-and-Expand	A flagship U.S. academic medical center adopts the system for its trauma service, creating a reference case for system-wide rollout.	A partnership with a top-tier U.S. hospital's orthopedic department.	The value proposition is framed in terms hospitals understand: reducing length of stay and readmissions to lower costs [Comeback Mobility].

Data Accuracy: YELLOW -- Market size figure is a founder quote; clinical study details and regulatory status are from company materials. Growth scenarios are plausible extrapolations from stated strategy.

Sources

1. [Comeback Mobility] ComeBack Mobility - Smart Crutch Tips & Mobility Recovery | https://comebackmobility.com/
2. [ZoomInfo, ~2023] ComeBack Mobility - Overview, News & Similar companies | https://www.zoominfo.com/c/comeback-mobility/546878674
3. [Perplexity Sonar Pro] Perplexity Sonar Pro Brief |
4. [Comeback Mobility request page] The challenges of using crutches - ComeBack Mobility | https://comebackmobility.com/challenges-of-using-crutches/
5. [Crunchbase] ComeBack Mobility - Crunchbase Company Profile & Funding | https://www.crunchbase.com/organization/comeback-mobility